Human stem cells are unspecialized cells found in all parts of the body. They have the ability to self-renew and differentiate into any cell in an organism. Both embryonic and adult cells contain stem cells. Through the implantation of stem cells, stem cell therapy is a promising technique for the regeneration of damaged organs, tissues, or functions. For decades, stem cell therapy has been available. In the recent decade, stem cell therapy has sparked a lot of interest in a variety of therapeutic approaches. Stem cells have the ability to reduce inflammation, improve regenerative potential, and boost growth. Stem cell–based therapy has tremendous potential for improving people's lives. Stem cell therapy research will continue to develop, with a bright future for new biological components used in the treatment of a variety of diseases.
The transplantation of human cells to repair or replace damaged tissue and/or cells is known as cellular therapy (CT). Many different types of cells may be used as part of a therapy or treatment for a number of diseases and disorders due to advances in technology, inventive products, and infinite imagination. Hematopoietic (blood-forming) stem cells (HSC), skeletal muscle stem cells, mesenchymal stem cells, lymphocytes, dendritic cells, and pancreatic islet cells are some of the cells that could be used. Various cell types will be developed into treatments as innovative cell therapies and examined for possible uses while the research is ongoing.
Title : Copper (II) complexes as potential anticancer agents
Salah S Massoud, University of Louisiana, United States
Title : Pharmacogenomics: current status and future directions
Matthias Schwab, University of Tübingen, Germany
Title : Talus bone of the hindfoot: Unique anatomy and an important clinical implication
Abdelmonem Awad Hegazy, Zarqa University, Jordan
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Effect of Fluvoxamine on Interluekin-6 level of COVID-19 patients, hospitalized in ICU: A randomized clinical trial
Mitra Safa, Shahid Beheshti University of Medical Sciences, Iran (Islamic Republic of)
Title : Precision Treatment of Alzheimer's
Boris Tankhilevich, Magtera, Inc., United States